Buscar
14/05/2022
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV) a randomised controlled trial
Delgado-Lista J., Alcala-Diaz J.F., Torres-Peña J.D., Quintana-Navarro G.M., Fuentes F., Garcia-Rios A., Ortiz-Morales A.M., Perez-Caballero A.I., Yubero-Serrano E.M., Rangel-Zuñiga O.A., Camargo A., Rodriguez-Cantalejo F., Lopez-Segura F., Badimon L., Ordovas J.M., Perez-Jimenez F., Perez-Martinez P., Lopez-Miranda J., Almaden Peña Y., Aranda E., Arenas de Larriva A.P., Badimon J.J., Blanco-Molina A., Blanco-Rojo R., Bolivar-Muñoz J., Caballero-Villarraso J., Chica J., Corina A., Criado-Garcia J., Cruz-Teno C., Daponte-Codina A., de Teresa Galvan E., Delgado-Casado N., Estruch R., Fernandez J.M., Fernandez-Gandara C., Fuentes-Jimenez F., Garcia-Carpintero Fernandez-Pacheco S., Gomez-Delgado F., Gomez-Garduño A., Gomez-Luna P., Gomez-Luna M.J., Gonzalez-Guardia L., Gonzalez-Requero A.I., Gutierrez-Mariscal F.M., Haro-Mariscal C.M., Jimenez-Lucena R., Jimenez-Morales A.I., Leon-Acuña A., Marin-Hinojosa C., Meneses Alvarez M.E., Mesa-Luna D., Moya-Garrido M.N., Muñoz-Carvajal I., Navarro-Martos V., Ochoa J.J., Ortiz-Minuesa J.A., Pan M., Peña-Orihuela P., Perez-Corral I., Pi-Sunyer F.X., Ramirez-Lara I., Rodriguez-Artalejo F., Romero M.A., Roncero-Ramos I., Ruano-Ruiz J.A., Ruiz de Castroviejo J., Sanchez-Villegas P., Suarez de Lezo J., Vals-Delgado C., Valverde R., Visioli F.. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV) a randomised controlled trial. LANCET. 2022; 399(10338)DOI:10.1016/S0140-6736(22)00122-2. PMID:35525255. IF:168.900(Q1/1D).
14/05/2022
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Ma, CX, Ma, XN, Guan, CH, Li, YD, Mauricio, D, Fu, SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01516-6. PMID:35568946. IF:9.300(Q1/1D).
13/05/2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease (vol 17, pg 1, 2022)
Visser, PJ, Reus, LM, Gobom, J, Jansen, I, Dicks, E, van der Lee, SJ, Tsolaki, M, Verhey, FRJ, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleo, A, Molinuevo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Sleegers, K, Dobricic, V, Lovestone, S, Streffer, J, Vos, SJB, Bos, I, Smit, AB, Blennow, K, Scheltens, P, Teunissen, CE, Bertram, L, Zetterberg, H, Tijms, BM. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease (vol 17, pg 1, 2022). Molecular Neurodegeneration. 2022; 17(1)DOI:10.1186/s13024-022-00540-0. PMID:35550177. IF:15.100(Q1/1D).
12/05/2022
Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019
Badia-Cebada, L, Penafiel, J, Saliba, P, Andres, M, Camara, J, Domenech, D, Jimenez-Martinez, E, Marron, A, Moreno, E, Pomar, V, Vaque, M, Limon, E, Masats, U, Pujol, M, Gasch, O. Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019. Eurosurveillance. 2022; 27(19)DOI:10.2807/1560-7917.ES.2022.27.19.2100610. PMID:35551704. IF:19.000(Q1/1D).